Sound Income Strategies’s Tvardi Therapeutics TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2
Closed -$6 2553
2026
Q1
$6 Hold
2
﹤0.01% 2583
2025
Q4
$9 Hold
2
﹤0.01% 2505
2025
Q3
$86 Hold
2
﹤0.01% 1628
2025
Q2
$47 Buy
+2
New +$47 ﹤0.01% 1561
2024
Q4
Sell
-3
Closed -$31 1558
2024
Q3
$31 Hold
3
﹤0.01% 1378
2024
Q2
$26 Hold
3
﹤0.01% 1350
2024
Q1
$91 Hold
3
﹤0.01% 1303
2023
Q4
$74 Hold
3
﹤0.01% 1287
2023
Q3
$168 Hold
3
﹤0.01% 1116
2023
Q2
$283 Hold
3
﹤0.01% 1064
2023
Q1
$491 Hold
3
﹤0.01% 992
2022
Q4
$1.07K Hold
3
﹤0.01% 851
2022
Q3
$1K Hold
3
﹤0.01% 860
2022
Q2
$1K Hold
3
﹤0.01% 866
2022
Q1
$1K Hold
3
﹤0.01% 857
2021
Q4
$1K Hold
3
﹤0.01% 821
2021
Q3
$2K Hold
3
﹤0.01% 718
2021
Q2
$1K Hold
3
﹤0.01% 854
2021
Q1
$2.17K Hold
3
﹤0.01% 761
2020
Q4
$2K Hold
3
﹤0.01% 742
2020
Q3
$1K Hold
3
﹤0.01% 805
2020
Q2
$2K Hold
3
﹤0.01% 663
2020
Q1
$1K Buy
+3
New +$1.63K ﹤0.01% 726

Other funds holding TVRD

Sound Income Strategies's TVRD Position: Q2 2026 in Review

Sound Income Strategies sold out of Tvardi Therapeutics (TVRD) in Q2 2026, closing a stake of 2 shares — an estimated $6 sold.

Sound Income Strategies first reported a position in TVRD in Q1 2020 and held it in 23 quarters. The position peaked at $2.17K in Q1 2021. 34 funds tracked by Wall St. Rank hold TVRD as of Q2 2026.

  • Sound Income Strategies reported no remaining Tvardi Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 2 Tvardi Therapeutics shares in Q2 2026, an estimated $6.
  • Sound Income Strategies first reported a position in Tvardi Therapeutics in Q1 2020 and held it in 23 quarters.
  • Sound Income Strategies's Tvardi Therapeutics position peaked at $2.17K in Q1 2021.
  • 34 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.